CHPA and members of our Dietary Supplements Committee appreciate the opportunity to comment on the recently released Draft Guidance outlining FDA’s approach to food allergen labeling.
The purpose of this cybersecurity and data privacy regulatory scan is to understand the current and forthcoming regulatory landscape related to cybersecurity and consumer data privacy.
Don't miss CHPA President & CEO, Scott Melville's insights on the consumer healthcare industry for the year ahead. Check out this article from Chain Drug Review.
The Consumer Healthcare Products Association (CHPA) today released findings from its 2022 Over-The-Counter (OTC) Value Study, once again showing that self-care with OTC medicines not only benefits individuals but also benefits the entire healthcare system.
In general, members are very satisfied with the existing regulations for content on the PDP, and recommend that no additional guidance on this topic is needed.
